Sofinnova BioEquities Enhanced Master Fund, LP — Form D
Sofinnova BioEquities Enhanced Master Fund, LP of MENLO PARK, CA, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2022-10-13. $2.0M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2022-10-13
- Form: D
- Accession: 0000919574-22-005947
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.7
- Amount sold: $2.0M
- Investors: 2
- Date of first sale: 2022-10-03
- Security types: equity, fund interests
- SEC file number: 021-461670
Issuer
- Name: Sofinnova BioEquities Enhanced Master Fund, LP
- CIK: 0001949475
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 3000 SAND HILL ROAD, MENLO PARK, CA, 94025
- Phone: 650-681-8482
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| -- Sofinnova Investments, Inc. | Executive Officer | Menlo Park, CA |
| -- Sofinnova Investments, Inc. | Promoter | Menlo Park, CA |
| -- Sofinnova BioEquities GP LLC | Executive Officer | Menlo Park, CA |
| -- Sofinnova BioEquities GP LLC | Promoter | Menlo Park, CA |
Other filings by this issuer (3)
More